Glanbia PLC ADS (GLAPY) Financials Oct 10, 2014, 12:00
Glanbia PLC ADS (GLAPY) Financials Oct 10, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Glanbia PLC ADS
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.83B 2.17B 1.93B 2.21B 2.38B
Cost of Goods Sold (COGS) incl. D&A 1.53B 1.8B 1.52B 1.74B 1.95B
COGS excluding D&A 1.48B 1.76B 1.48B 1.69B 1.91B
Depreciation & Amortization Expense 42.59M 47.68M 40.52M 44.88M 48.21M
Depreciation 28.74M 32.57M 22.57M 25.01M 27.2M
Amortization of Intangibles 13.86M 15.11M 17.95M 19.86M 21.01M
Gross Income 305M 363.45M 410.57M 474.52M 427.29M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 194.55M 226.95M 287.03M 315.37M 260.06M
Research & Development 7.69M 8.04M 8.4M 9.39M 7.72M
Other SG&A 186.86M 218.91M 278.64M 305.97M 252.34M
Other Operating Expense 2.54M 0 0 0 0
Unusual Expense (37.51M) (2.63M) 10.32M 4.5M (5.8M)
EBIT after Unusual Expense 37.51M 2.63M (10.32M) (4.5M) 5.8M
Non Operating Income/Expense (1.09M) (4.47M) 1.44M 3.82M (691,000)
Non-Operating Interest Income 5.54M 3.29M 3.06M 2.94M 2.17M
Equity in Affiliates (Pretax) 0 0 - 0 0
Interest Expense 17.06M 13.34M 26.47M 23.37M 24.99M
Gross Interest Expense 17.06M 13.34M 26.47M 23.37M 24.99M
Interest Capitalized 0 0 0 0 0
Pretax Income 132.81M 124.62M 91.25M 138.05M 149.52M
Income Tax 29.87M 26.09M 21.57M 24.17M 25.01M
Income Tax - Current Domestic (321,000) 11.2M 4.16M 7.31M 10.75M
Income Tax - Current Foreign 4.94M 3.34M 7.76M 16.4M 12.39M
Income Tax - Deferred Domestic 25.25M 11.55M 9.65M 465,000 1.87M
Income Tax - Deferred Foreign 0 0 - 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 10.23M 10.1M 14.33M 12.15M 26.49M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 113.16M 108.63M 84.01M 126.02M 151M
Minority Interest Expense 483,000 586,000 630,000 440,000 666,000
Net Income 112.68M 108.05M 83.38M 125.58M 150.33M
Extraordinaries & Discontinued Operations 0 0 28.8M 19.37M 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 (7.76M) 0
Cumulative Effect - Accounting Chg 0 0 0 - 0
Discontinued Operations 0 0 28.8M 27.13M 0
Net Income After Extraordinaries 112.68M 108.05M 112.18M 144.96M 150.33M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 112.68M 108.05M 83.38M 125.58M 150.33M
EPS (Basic) 0.38 0.37 0.38 0.52 0.51
Basic Shares Outstanding 292.99M 293.11M 293.54M 294.02M 294.71M
EPS (Diluted) 0.38 0.37 0.38 0.51 0.51
Diluted Shares Outstanding 293.82M 294.98M 295.95M 296.69M 296.75M
EBITDA 150.5M 184.19M 164.06M 204.03M 215.44M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...
Continue Reading
Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...
Continue Reading
New Defense Fronts: Canada and Ukraine Join Forces October 13, 2026, marks an important day in Ottawa's defense narrative with Dominion Dynamics and Ukraine's TENCORE kicking off a robust partnership. They're not just collaborating; they're plugging into each other's strengths to build TerMIT uncrewed ground vehicles (UGVs) on Canadian soil. These aren't gizmos you find...
Continue Reading
A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....
Continue Reading
Untangling the Web of Global Battery Compliance Amid clamor about AI's insatiable appetite for energy storage, the rules around shipping, installing, and handling data center batteries have become a tangled web. From Waxahachie, Texas, Americase International plans to take the stage at the OCP Global Summit on October 15, 2026, to spearhead a discussion on bridging the...
Continue Reading
Gearing Up: Franco-Nevada's Q3 Numbers on the Horizon You know the drill! Franco-Nevada's third quarter results won't just trickle in—they'll set the tone for the months ahead. Mark your calendar: November 11th after the market closes is the magic hour when you'll get the skinny on their Q3 performance. The next morning, bright and early at 8:00 AM ET, they'll hash it...
Continue Reading
Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...
Continue Reading
A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...
Continue Reading
If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...
Continue Reading
Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...
Continue Reading
Top 5 Most Recently Viewed Articles
LET Mining Unveils Innovative Cloud Mining Services The cryptocurrency landscape is buzzing, and among the stars is XRP, drawing significant interest from investors. LET Mining stands at the forefront with its cutting-edge cloud mining service program, specifically designed to cater to XRP holders. This innovative service allows users to pay for mining contracts using...
Continue Reading
Biden Administration Expands Clean Energy Tax Credit Guidance The Biden administration has recently unveiled guidance aimed at assisting companies in obtaining clean energy tax credits as part of the 2022 Inflation Reduction Act. This initiative finalizes a program designed to broaden subsidies that have traditionally supported wind and solar energy to a wider array of...
Continue Reading
Introduction In recent developments, Sable Offshore Corp. has found itself under scrutiny as investors come forward to initiate legal action against the company. As a key player in the offshore oil production industry, the events surrounding Sable Offshore's operations have raised eyebrows Legal Investigation Background The law firm Faruqi & Faruqi, LLP, which specializes...
Continue Reading
The Emerging Landscape of MET Targeting Therapies The MET targeting therapies market is on the brink of significant expansion. With increasing cancer diagnoses and heightened awareness surrounding MET-targeting options, industry stakeholders are poised for transformative changes. Companies are exploring various MET-targeted therapies under clinical trials, promising a...
Continue Reading
Understanding CEO Reputation and Safety in Today's Business Environment In recent discussions about executive safety, the focus has notably shifted since the tragic murder of a notable healthcare CEO. This incident has sparked vital dialogues concerning the safety of high-profile executives and the dynamic between their reputation and the management of customer...
Continue Reading